Compare ALEMBIC PHARMA with ASTRAZENECA PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs ASTRAZENECA PHARMA - Comparison Results

ASTRAZENECA PHARMA 
   Change

AstraZeneca Pharma India Limited (APIL) is a 90% subsidiary of the UK based AstraZeneca Pharmaceuticals, which is one of the world's leading pharma companies. APIL has interests in the six crucial areas of cardiovascular, respiratory, maternal health... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA ASTRAZENECA PHARMA ALEMBIC PHARMA/
ASTRAZENECA PHARMA
 
P/E (TTM) x 15.7 116.0 13.5% View Chart
P/BV x 6.2 35.5 17.5% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 ALEMBIC PHARMA   ASTRAZENECA PHARMA
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-19
ASTRAZENECA PHARMA
Mar-18
ALEMBIC PHARMA/
ASTRAZENECA PHARMA
5-Yr Chart
Click to enlarge
High Rs6641,278 52.0%   
Low Rs412883 46.7%   
Sales per share (Unadj.) Rs208.7228.4 91.4%  
Earnings per share (Unadj.) Rs31.010.4 299.1%  
Cash flow per share (Unadj.) Rs37.116.3 228.2%  
Dividends per share (Unadj.) Rs5.500-  
Dividend yield (eoy) %1.00-  
Book value per share (Unadj.) Rs144.298.8 146.0%  
Shares outstanding (eoy) m188.5225.00 754.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.64.7 54.5%   
Avg P/E ratio x17.4104.2 16.7%  
P/CF ratio (eoy) x14.566.4 21.8%  
Price / Book Value ratio x3.710.9 34.1%  
Dividend payout %17.70-   
Avg Mkt Cap Rs m101,46127,008 375.7%   
No. of employees `000NA1.4 0.0%   
Total wages/salary Rs m7,4671,535 486.3%   
Avg. sales/employee Rs ThNM4,210.9-  
Avg. wages/employee Rs ThNM1,132.2-  
Avg. net profit/employee Rs ThNM191.1-  
INCOME DATA
Net Sales Rs m39,3475,710 689.1%  
Other income Rs m94123 76.6%   
Total revenues Rs m39,4415,833 676.2%   
Gross profit Rs m8,736463 1,887.2%  
Depreciation Rs m1,152147 781.8%   
Interest Rs m1840-   
Profit before tax Rs m7,493438 1,710.8%   
Minority Interest Rs m110-   
Prior Period Items Rs m-930-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,568179 876.2%   
Profit after tax Rs m5,844259 2,255.4%  
Gross profit margin %22.28.1 273.9%  
Effective tax rate %20.940.8 51.2%   
Net profit margin %14.94.5 327.3%  
BALANCE SHEET DATA
Current assets Rs m19,5773,209 610.0%   
Current liabilities Rs m14,8962,070 719.8%   
Net working cap to sales %11.920.0 59.6%  
Current ratio x1.31.6 84.8%  
Inventory Days Days9072 124.1%  
Debtors Days Days4535 129.9%  
Net fixed assets Rs m27,097790 3,428.7%   
Share capital Rs m37750 754.0%   
"Free" reserves Rs m26,8112,419 1,108.2%   
Net worth Rs m27,1882,469 1,101.0%   
Long term debt Rs m4,9930-   
Total assets Rs m47,7784,605 1,037.4%  
Interest coverage x41.7NM-  
Debt to equity ratio x0.20-  
Sales to assets ratio x0.81.2 66.4%   
Return on assets %12.65.6 224.3%  
Return on equity %21.510.5 204.8%  
Return on capital %23.617.7 133.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m19,453300 6,494.0%   
Fx outflow Rs m6,0652,015 301.0%   
Net fx Rs m13,388-1,715 -780.5%   
CASH FLOW
From Operations Rs m8,12088 9,237.3%  
From Investments Rs m-7,556-94 8,072.6%  
From Financial Activity Rs m590NA-  
Net Cashflow Rs m1,153-6 -20,233.3%  

Share Holding

Indian Promoters % 74.1 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 2.9 0.3 966.7%  
FIIs % 9.1 15.7 58.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 13.9 9.1 152.7%  
Shareholders   49,328 12,856 383.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   TORRENT PHARMA  DR. DATSONS LABS  CADILA HEALTHCARE  SANOFI INDIA  PANACEA BIOTECH  

Compare ALEMBIC PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 257 Points Higher, Coal India and UPL Among Top Gainers(Closing)

Indian share markets continued their positive trend during closing hours today and ended their day on a firm note.

Related Views on News

ASTRAZENECA PHARMA Announces Quarterly Results (3QFY21); Net Profit Down 21.2% (Quarterly Result Update)

Feb 11, 2021 | Updated on Feb 11, 2021

For the quarter ended December 2020, ASTRAZENECA PHARMA has posted a net profit of Rs 211 m (down 21.2% YoY). Sales on the other hand came in at Rs 2 bn (down 10.5% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 13.8% (Quarterly Result Update)

Jan 19, 2021 | Updated on Jan 19, 2021

For the quarter ended December 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 13.8% YoY). Sales on the other hand came in at Rs 13 bn (up 8.7% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 30.0% (Quarterly Result Update)

Oct 23, 2020 | Updated on Oct 23, 2020

For the quarter ended September 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 30.0% YoY). Sales on the other hand came in at Rs 15 bn (up 17.4% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ASTRAZENECA PHARMA Announces Quarterly Results (1QFY21); Net Profit Down 13.4% (Quarterly Result Update)

Sep 22, 2020 | Updated on Sep 22, 2020

For the quarter ended June 2020, ASTRAZENECA PHARMA has posted a net profit of Rs 186 m (down 13.4% YoY). Sales on the other hand came in at Rs 2 bn (down 5.4% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

ASTRAZENECA PHARMA Announces Quarterly Results (4QFY20); Net Profit Down 2.5% (Quarterly Result Update)

May 20, 2020 | Updated on May 20, 2020

For the quarter ended March 2020, ASTRAZENECA PHARMA has posted a net profit of Rs 96 m (down 2.5% YoY). Sales on the other hand came in at Rs 2 bn (up 2.4% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

More Views on News

Most Popular

Intraday Trading for a Living(Fast Profits Daily)

Feb 15, 2021

In this video, I'll cover your queries on intraday trading and also share my view on how to decide stop losses and target prices.

Penny Stock Master Series: The Quest for 10X Profits in 10 Years(Profit Hunter)

Feb 12, 2021

This is first of the three part master series. In these editorials, I'll show you how to earn 10X returns from a penny stock portfolio over 10 years.

Top 5 Stocks Mutual Funds Bought and Sold in January 2021(Sector Info)

Feb 16, 2021

A look at what India's top equity mutual funds bought and sold in January 2021.

I Would Recommend this Small-cap Stock Over Tesla(Profit Hunter)

Feb 16, 2021

Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Feb 25, 2021 (Close)

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA - AJANTA PHARMA COMPARISON

COMPARE ALEMBIC PHARMA WITH

MARKET STATS